Surgical net sales, which include implantables, consumables and equipment/other, were $1.5 billion, an increase of 2% on a reported basis and 1% on a constant currency basis versus the second quarter ...

Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS capabilities. Regulatory clearance was a closing condition; both parties ...

Stonesifer reaffirmed guidance: "Sales remained on track at $10.3 billion to $10.4 billion with constant currency growth of 4% to 5%, and we continue to expect acceleration in the fourth quarter ...

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: ...

Alcon, Inc. ALC delivered second-quarter 2025 core earnings per share (EPS) of 76 cents, up 2.7% from the year-ago quarter’s figure. At the constant exchange rate or CER, the figure increased 1% year ...

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, citing increased tariff impact. The company forecasts a full-year ...

Sustainable Growth Advisers (SGA), an investment management company, released its fourth-quarter investor letter for its “Emerging Markets Growth Strategy.” A copy of the letter can be downloaded here ...

Alcon, an international eye care company with facilities in Berks County, has announced it plans to acquire STAAR Surgical Co. Under the terms of the agreement announced Tuesday, Alcon will purchase ...

STAAR Surgical Company (NASDAQ:STAA) is one of the 11 Best Short-Term Stocks to Invest in. Significant price movements were noted this week following the announcement of a takeover agreement from ...

GENEVA, SWITZERLAND – When Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reduced its full-year projections in the second quarter, Wall Street punished ...